Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Emilio Sternieri"'
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 11:1127-1144
Chronic migraine is often complicated by medication-overuse headache (MOH), a headache due to excessive intake of acute medications. Chronic migraine and MOH are serious and disabling disorders. Since chronic migraine derives from the progression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3c37c18866bfd014104791c9106fae
https://doi.org/10.1517/17425255.2015.1043265
https://doi.org/10.1517/17425255.2015.1043265
Publikováno v:
The Journal of Headache and Pain
There are a large number of drugs inducing headache as an adverse reaction. Nevertheless, headaches as adverse reactions to drugs have received limited attention. Non-serious adverse reactions, such as headache, are not quantified and described as ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccedab9db0ebee13923166ad9402b823
https://doi.org/10.1007/s10194-009-0127-1
https://doi.org/10.1007/s10194-009-0127-1
Publikováno v:
European Journal of Clinical Pharmacology. 64:489-495
The marketing of sumatriptan, a selective serotonin (5-HT) 1B/1D agonist, first of the class of triptans, has increased the therapeutic options for the treatment of migraine attacks. However, almost one third of patients in clinical trials fail to ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9b493fc5bf4a602a4b7b8bdbecea31
https://doi.org/10.1007/s00228-007-0443-9
https://doi.org/10.1007/s00228-007-0443-9
Publikováno v:
European Journal of Neurology. 12:759-767
In this double-blind, randomized, parallel group, multicentre study the efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine (IndoProCaf) and nimesulide were compared over an 8-h period in the treatment of two consecutive e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40323a2898dc4636626d0c1d1cc66208
https://doi.org/10.1111/j.1468-1331.2005.01056.x
https://doi.org/10.1111/j.1468-1331.2005.01056.x
Autor:
Giovanna Santoro, Mila Ferri, Edoardo Polidori, A. Zaimovic, Emilio Sternieri, Gilberto Gerra
Publikováno v:
Journal of Substance Abuse Treatment. 25:1-8
Data were collected from 265 heroin-dependent patients in long-term methadone maintenance treatment for methadone dosage, administration method, illicit drug and problematic alcohol use, psychiatric diagnoses, quality of interpersonal relationships,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffd0bc545ff4f9fc6de0da52bc3ea7b0
https://doi.org/10.1016/s0740-5472(03)00031-x
https://doi.org/10.1016/s0740-5472(03)00031-x
Publikováno v:
Drug and Alcohol Dependence. 52:211-220
The pharmacokinetics of naltrexone have been scarcely explored in patients during chronic treatment despite the observation that the pharmacological effect of the drug is related to its plasma concentrations. In this study we investigated the time co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9526bf9fb7b58af813cf39ad279429c8
https://doi.org/10.1016/s0376-8716(98)00098-2
https://doi.org/10.1016/s0376-8716(98)00098-2
Autor:
Marco Bertolotti, Giovanni Vitale, F. H. J. Wolfhagen, Wim C. J. Hop, H. R. Van Buuren, Emilio Sternieri
Publikováno v:
Gastroenterology, 113, 1264-1269. W.B. Saunders
The efficacy of currently available therapeutic agents for cholestatic pruritus is often disappointing. The aim of this study was to assess the antipruritic effect of naltrexone, an oral opiate receptor antagonist.Sixteen patients with pruritus of ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b08bba11691ffa2c563071a7b5a8b9e6
https://doi.org/10.1053/gast.1997.v113.pm9322521
https://doi.org/10.1053/gast.1997.v113.pm9322521
Autor:
Anna Ferrari, Francesca Carubbi, Tommaso Trenti, Marco Bertolotti, M Stefani, Paola Loria, Emilio Sternieri, Nicola Carulli, Giovanni Vitale
Publikováno v:
Journal of Hepatology. 27:505-511
Naltrexone is a competitive opiate antagonist with high hepatic extraction. It is used for detoxification treatment for heroin addicts and has been proposed as a possible treatment of pruritus in cholestasis. Such patients are likely to have impaired
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::440ede08091c3232c1e0aaea7f55b2e6
https://doi.org/10.1016/s0168-8278(97)80355-8
https://doi.org/10.1016/s0168-8278(97)80355-8
Autor:
Diego Pinetti, Emilio Sternieri, Anna Ferrari, Ciro Pio Rosario Coccia, Sheila Leone, Alfio Bertolini
Publikováno v:
The Journal of Headache and Pain
Sumatriptan is a selective agonist of 5HT1 (1B/1D) receptors, which has proved to be effective and safe for the acute treatment of migraine attacks. Nevertheless, its use by migraine sufferers is still limited and some patients consider adverse react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1728f1ea0279ef32667a1dd417801645
https://doi.org/10.1007/s10194-005-0220-z
https://doi.org/10.1007/s10194-005-0220-z